Adelante Capital Management LLC lessened its position in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 92.5% in the fourth quarter, Holdings Channel reports. The fund owned 26,052 shares of the real estate investment trust’s stock after selling 321,003 shares during the quarter. Adelante Capital Management LLC’s holdings in Healthpeak Properties were worth $528,000 as of its most recent filing with the SEC.
Other hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Diamant Asset Management Inc. purchased a new stake in Healthpeak Properties in the third quarter worth about $564,000. Vert Asset Management LLC increased its position in Healthpeak Properties by 11.1% in the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust’s stock worth $6,167,000 after buying an additional 30,461 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Healthpeak Properties by 25.7% in the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust’s stock worth $2,213,000 after buying an additional 22,300 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in Healthpeak Properties by 16.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust’s stock worth $2,217,000 after buying an additional 15,753 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Trading Up 0.2 %
Shares of DOC opened at $17.78 on Wednesday. The company’s fifty day moving average is $19.49 and its 200 day moving average is $20.51. Healthpeak Properties, Inc. has a fifty-two week low of $17.33 and a fifty-two week high of $23.26. The stock has a market capitalization of $12.44 billion, a PE ratio of 50.80, a P/E/G ratio of 2.17 and a beta of 1.02. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.
Healthpeak Properties Dividend Announcement
The firm also recently declared a dividend, which will be paid on Wednesday, April 30th. Investors of record on Friday, April 18th will be given a $0.1017 dividend. This represents a yield of 6.5%. The ex-dividend date is Thursday, April 17th. Healthpeak Properties’s dividend payout ratio is presently 305.00%.
Insider Buying and Selling
In other news, Director John T. Thomas acquired 4,200 shares of the business’s stock in a transaction on Monday, April 28th. The shares were acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now directly owns 813,566 shares of the company’s stock, valued at approximately $14,514,017.44. The trade was a 0.52 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Scott M. Brinker acquired 11,337 shares of the business’s stock in a transaction on Monday, April 28th. The shares were purchased at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the transaction, the chief executive officer now directly owns 201,863 shares of the company’s stock, valued at approximately $3,568,937.84. The trade was a 5.95 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.23% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of analysts have commented on DOC shares. Argus restated a “buy” rating and issued a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday. Evercore ISI cut their target price on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Monday. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, April 23rd. Robert W. Baird cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Tuesday. Finally, Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus price target of $23.42.
View Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- How to Calculate Inflation Rate
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.